Means Investment CO. Inc. Sells 2,740 Shares of iShares Biotechnology ETF $IBB

Means Investment CO. Inc. lessened its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 29.4% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 6,583 shares of the financial services provider’s stock after selling 2,740 shares during the period. Means Investment CO. Inc.’s holdings in iShares Biotechnology ETF were worth $833,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in IBB. Signet Financial Management LLC raised its position in iShares Biotechnology ETF by 3.3% in the second quarter. Signet Financial Management LLC now owns 2,579 shares of the financial services provider’s stock worth $326,000 after acquiring an additional 83 shares during the period. Apollon Wealth Management LLC increased its stake in shares of iShares Biotechnology ETF by 1.1% in the 1st quarter. Apollon Wealth Management LLC now owns 8,754 shares of the financial services provider’s stock worth $1,120,000 after purchasing an additional 96 shares in the last quarter. SBI Securities Co. Ltd. increased its stake in shares of iShares Biotechnology ETF by 5.2% in the 1st quarter. SBI Securities Co. Ltd. now owns 2,198 shares of the financial services provider’s stock worth $281,000 after purchasing an additional 108 shares in the last quarter. KFG Wealth Management LLC raised its holdings in iShares Biotechnology ETF by 4.8% in the 2nd quarter. KFG Wealth Management LLC now owns 2,444 shares of the financial services provider’s stock worth $309,000 after purchasing an additional 112 shares during the period. Finally, QRG Capital Management Inc. lifted its position in iShares Biotechnology ETF by 5.3% during the second quarter. QRG Capital Management Inc. now owns 2,437 shares of the financial services provider’s stock valued at $308,000 after purchasing an additional 123 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.4%

IBB stock opened at $149.95 on Friday. iShares Biotechnology ETF has a twelve month low of $107.43 and a twelve month high of $153.01. The business’s 50-day moving average price is $140.94 and its 200-day moving average price is $130.59.

iShares Biotechnology ETF Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were issued a dividend of $0.0828 per share. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $0.33 annualized dividend and a yield of 0.2%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.